[{"address1": "900 Middlefield Road", "address2": "4th Floor", "city": "Redwood City", "state": "CA", "zip": "94063", "country": "United States", "phone": "650 980 9099", "website": "https://biomeafusion.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Biomea Fusion, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, a covalent inhibitor of menin for treating patients with liquid and solid tumors and type 2 diabetes. The company was incorporated in 2017 and is headquartered in Redwood City, California.", "fullTimeEmployees": 112, "companyOfficers": [{"maxAge": 1, "name": "Mr. Thomas Andrew Butler", "age": 42, "title": "Co-Founder, Chairman & CEO", "yearBorn": 1981, "fiscalYear": 2023, "totalPay": 950407, "exercisedValue": 0, "unexercisedValue": 5655125}, {"maxAge": 1, "name": "Mr. Ramses M. Erdtmann", "age": 60, "title": "Co-Founder, President, COO & Director", "yearBorn": 1963, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Franco  Valle", "age": 42, "title": "CFO & Principal Accounting Officer", "yearBorn": 1981, "fiscalYear": 2023, "totalPay": 673659, "exercisedValue": 0, "unexercisedValue": 687866}, {"maxAge": 1, "name": "Dr. Juan Pablo Frias M.D.", "title": "Chief Medical Officer", "fiscalYear": 2023, "totalPay": 492250, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Heow  Tan", "age": 64, "title": "Chief Technology & Quality Officer", "yearBorn": 1959, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Naomi  Cretcher", "title": "Chief People Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Thorsten  Kirschberg Ph.D.", "age": 53, "title": "Executive Vice President of Chemistry", "yearBorn": 1970, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Stephan  Morris M.D.", "title": "Chief Development Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Ravi  Upasani", "title": "Executive Vice President of Intellectual Property", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Caroline  Perez- Dupont", "title": "Senior Vice President of Contracts", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 6, "boardRisk": 9, "compensationRisk": 9, "shareHolderRightsRisk": 8, "overallRisk": 8, "governanceEpochDate": 1724803200, "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 2, "previousClose": 7.62, "open": 7.7, "dayLow": 6.95, "dayHigh": 7.96, "regularMarketPreviousClose": 7.62, "regularMarketOpen": 7.7, "regularMarketDayLow": 6.95, "regularMarketDayHigh": 7.96, "beta": -0.538, "forwardPE": -2.1432748, "volume": 1320177, "regularMarketVolume": 1320177, "averageVolume": 1346144, "averageVolume10days": 823040, "averageDailyVolume10Day": 823040, "bid": 7.31, "ask": 7.37, "bidSize": 100, "askSize": 100, "marketCap": 265420768, "fiftyTwoWeekLow": 3.61, "fiftyTwoWeekHigh": 22.74, "fiftyDayAverage": 5.6287, "twoHundredDayAverage": 11.638225, "currency": "USD", "enterpriseValue": 162476528, "floatShares": 22436906, "sharesOutstanding": 36210200, "sharesShort": 7142807, "sharesShortPriorMonth": 7903014, "sharesShortPreviousMonthDate": 1721001600, "dateShortInterest": 1723680000, "sharesPercentSharesOut": 0.1973, "heldPercentInsiders": 0.25006, "heldPercentInstitutions": 0.64998, "shortRatio": 9.2, "shortPercentOfFloat": 0.3214, "impliedSharesOutstanding": 36210200, "bookValue": 2.873, "priceToBook": 2.55134, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1719705600, "netIncomeToCommon": -139650000, "trailingEps": -3.9, "forwardEps": -3.42, "enterpriseToEbitda": -1.107, "52WeekChange": -0.56081486, "SandP52WeekChange": 0.2560848, "exchange": "NMS", "quoteType": "EQUITY", "symbol": "BMEA", "underlyingSymbol": "BMEA", "shortName": "Biomea Fusion, Inc.", "longName": "Biomea Fusion, Inc.", "firstTradeDateEpochUtc": 1618579800, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "bc0a49f6-c4ed-3d62-b67c-2f5f0de07165", "messageBoardId": "finmb_695310535", "gmtOffSetMilliseconds": -14400000, "currentPrice": 7.33, "targetHighPrice": 60.0, "targetLowPrice": 5.0, "targetMeanPrice": 22.57, "targetMedianPrice": 21.0, "recommendationMean": 2.1, "recommendationKey": "buy", "numberOfAnalystOpinions": 7, "totalCash": 113286000, "totalCashPerShare": 3.129, "ebitda": -146722000, "totalDebt": 10342000, "quickRatio": 4.502, "currentRatio": 4.621, "debtToEquity": 9.949, "returnOnAssets": -0.48203, "returnOnEquity": -0.85086995, "freeCashflow": -63627500, "operatingCashflow": -111409000, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-09-01"}]